Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Factor Support in Locally Advanced NSCLC
NCT00682383Phase 2Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Sep 2003
- Primary completion
- Jan 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim, filgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Mount Sinai Medical Center. Started Sep 2003; status: completed.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT00682383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682383.